Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Big Pharma Split Corp

Financial Services CA PRM.PA

10.21CAD
-0.09(0.87%)

Last update at 2026-06-22T15:49:00Z

Day Range

10.2110.28
LowHigh

52 Week Range

8.7110.38
LowHigh

Fundamentals

  • Previous Close 10.30
  • Market Cap0.00000M
  • Volume200
  • P/E Ratio2.97
  • Dividend Yield5.25%
  • Revenue TTM2.65M
  • Revenue Per Share TTM1.92
  • Gross Profit TTM 5.56M
  • Diluted EPS TTM3.27

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 3.15M 4.85M 0.27M 3.14M 2.78M
Minority interest - - - - -
Net income 3.15M 4.85M 0.27M 3.14M 2.78M
Selling general administrative 0.36M 0.37M 0.22M 0.29M 0.32M
Selling and marketing expenses - - - - -
Gross profit - - - 2.20M 6.40M
Reconciled depreciation - - - - -
Ebit - 4.61M 0.19M 1.76M 5.66M
Ebitda - - - 1.80M 5.95M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income - - - 1.80M 5.95M
Other operating expenses - 0.12M 0.10M 0.11M 0.12M
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 3.71M 5.36M 0.59M 2.43M 3.23M
Total operating expenses - - - 0.63M 0.73M
Cost of revenue - - - 0.24M 0.27M
Total other income expense net - - - 1.34M -3.16863M
Discontinued operations - - - - -
Net income from continuing ops 3.15M 4.85M 0.27M 3.14M 2.78M
Net income applicable to common shares - 4.21M -0.21739M 2.58M 2.10M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 39.10M 37.81M 22.93M 27.18M 33.63M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - 0.81M 0.04M 0.24M -
Total liab 19.37M 15.41M 9.75M 10.87M 14.79M
Total stockholder equity 19.73M 22.40M 13.19M 16.31M 18.84M
Deferred long term liab - - - - -
Other current liab - 0.55M 0.40M 0.29M 1.38M
Common stock - 22.40M 13.19M 16.31M 18.84M
Capital stock - - - - -
Retained earnings - - - - -
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.82M 1.43M 0.23M 0.54M 0.42M
Cash and equivalents - - - - -
Total current liabilities - 15.41M 9.75M 10.87M 14.79M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - - -
Total current assets - 2.50M 0.53M 0.84M 0.49M
Long term investments 24.27M 36.13M 22.45M - 33.14M
Net tangible assets - 22.40M 13.19M 16.31M 18.84M
Short term investments - - - 26.33M 33.14M
Net receivables - 0.25M 0.26M 0.07M 0.07M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.35M 0.34M 0.21M - 0.31M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - 0.00000M 0.00000M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments - - - - -
Change to liabilities - 0.00000M 0.00000M 0.00000M 0.00000M
Total cashflows from investing activities - - - - -
Net borrowings - - - - -
Total cash from financing activities - 10.19M -4.65203M -8.56934M -2.70952M
Change to operating activities - -0.15429M -0.03168M -0.00301M -0.05396M
Net income 3.15M 4.21M -0.21739M 2.58M 2.10M
Change in cash -0.60887M 1.20M -0.30506M 0.12M -1.42845M
Begin period cash flow 1.43M 0.23M 0.54M 0.42M 1.85M
End period cash flow 0.82M 1.43M 0.23M 0.54M 0.42M
Total cash from operating activities 1.13M -9.00036M 4.35M 8.68M 1.27M
Issuance of capital stock 0.88M 13.32M - - 0.00000M
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid 2.62M 2.84M 1.73M 2.08M 2.25M
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - -2.92095M -6.48549M -0.45609M
Other cashflows from financing activities - -0.29107M -0.29107M -0.29107M -0.29107M
Change to netincome - -13.05582M 4.60M 6.10M -0.78022M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.18M -0.15429M -0.03168M -0.00301M -0.05396M
Stock based compensation - - - - -
Other non cash items -0.00415M -0.23153M - 8.35M 2.38M
Free cash flow 1.13M -9.00036M 4.35M 8.68M 1.27M

Peer Comparison

Sector: Financial Services Industry: Asset Management

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
PRM-PA
Big Pharma Split Corp		 -0.09 0.87% 10.21 2.97 - - -
BLK
BlackRock CDR (CAD Hedged)		 0.21 0.79% 26.81 25.23 18.90 6.38 2.79 6.35 17.13
BN
Brookfield Corporation		 -0.39 0.62% 62.52 94.76 11.96 1.84 2.36 4.58 10.80
BAM
Brookfield Asset Management Ltd		 0.39 0.59% 66.82 31.22 25.51 22.40 9.70 17.61 25.08
PHYS
Sprott Physical Gold Trust		 0.62 1.41% 44.70 3.81 - 3.47 1.06 4.09 0.66

Reports Covered

Stock Research & News

View All

Profile

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Big Pharma Split Corp

610 Chartwell Road, Oakville, ON, Canada, L6j 4A5

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.